Biohaven 202 Study

Biohaven 202 Study


The Biohaven 202 Study is a 12-month migraine study of an investigational medication that is taken as needed for migraine headache in the form of a nasal spray.

You may qualify to participate if you:

  • Are at least 18 years of age
  • Experience migraines, and:
    • have 2 to 8 migraine headaches per month
    • and treat at least 2 migraine headaches per month with medication

For more information, please contact us at 617-744-1310.